Treatment of Diabetes in Hospitals With Noninsulin Medications Is a Research Priority
Diabetes Care
.
2024 Jun 1;47(6):915-917.
doi: 10.2337/dci23-0094.
Authors
Daisy Duan
1
,
Nestoras N Mathioudakis
1
,
Scott J Pilla
2
3
4
Affiliations
1
Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
2
Division of General Internal Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
3
Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, MD.
4
Department of Health Policy and Management, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD.
PMID:
38768334
PMCID:
PMC11116904
(available on
2025-06-01
)
DOI:
10.2337/dci23-0094
No abstract available
Publication types
Letter
Editorial
Comment
MeSH terms
Diabetes Mellitus* / drug therapy
Humans
Hypoglycemic Agents* / therapeutic use
Grants and funding
R01 DK122073/DK/NIDDK NIH HHS/United States
R01 DK134955/DK/NIDDK NIH HHS/United States
K23DK128572/DK/NIDDK NIH HHS/United States
K23 DK128572/DK/NIDDK NIH HHS/United States
R01 DK125780/DK/NIDDK NIH HHS/United States
K23 DK133690/DK/NIDDK NIH HHS/United States